[go: up one dir, main page]

HK1178550A - Human group p immunodeficiency virus and uses thereof - Google Patents

Human group p immunodeficiency virus and uses thereof Download PDF

Info

Publication number
HK1178550A
HK1178550A HK13106279.4A HK13106279A HK1178550A HK 1178550 A HK1178550 A HK 1178550A HK 13106279 A HK13106279 A HK 13106279A HK 1178550 A HK1178550 A HK 1178550A
Authority
HK
Hong Kong
Prior art keywords
immunodeficiency virus
human group
human
group
immunodeficiency
Prior art date
Application number
HK13106279.4A
Other languages
Chinese (zh)
Inventor
Catherine A Brennan
Vera Holzmayer
Anadruzela S Vallari
Julie Yamaguchi
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of HK1178550A publication Critical patent/HK1178550A/en

Links

HK13106279.4A 2010-02-16 2011-02-16 Human group p immunodeficiency virus and uses thereof HK1178550A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61/304,918 2010-02-16
US61/376,151 2010-08-23

Publications (1)

Publication Number Publication Date
HK1178550A true HK1178550A (en) 2013-09-13

Family

ID=

Similar Documents

Publication Publication Date Title
AU2016202543A1 (en) Human immunodeficiency virus (hiv)-neutralizing antibodies
EP2614064B8 (en) Inhibitors of human immunodeficiency virus replication
PL2408476T3 (en) Human immunodeficiency virus (hiv) -neutralizing antibodies
ZA201207331B (en) Concentrated protein formulations and uses thereof
PT3494972T (en) Combinations of dolutegravir and lamivudine for the treaetment of hiv infection
EP2566957B8 (en) Vaccine against beta-herpesvirus infection and use thereof
EP2622530A4 (en) Hardware-based human presence detection
EP2892913A4 (en) Peptides and their uses
ZA201406382B (en) Levoisovalerylspiramycin i,ii,iii and preparations ,preparation methods and uses thereof
WO2011126882A9 (en) Therapeutic peptides and their derivatives and therapeutic uses thereof
PT2563806E (en) Human leukolectins and uses thereof
AU2011259204A1 (en) Antigen peptide and use thereof
AU2011259204A8 (en) Antigen peptide and use thereof
HK1178550A (en) Human group p immunodeficiency virus and uses thereof
EP2638160B8 (en) Nuclions and ribocapsids
HK1175998A (en) Peptides and their use
AU2010904801A0 (en) Seleno-Compounds and Therapeutic Uses Thereof
AU2011903400A0 (en) Modified human rotaviruses and uses therefor
AU2010903774A0 (en) Modified human rotaviruses and uses therefor
HK1183903A (en) C18orf54 peptides and vaccines including the same
HK1183902A (en) Wdhd1 peptides and vaccines including the same
AU2012905160A0 (en) Implant and uses thereof
HK1180595A (en) Concentrated protein formulations and uses thereof
HK1180699A (en) Cdca5 peptides and vaccines including the same
HK1194078A (en) Human tissue factor antibody and uses thereof